Clopidogrel
Showing 1 - 25 of 1,574
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
- Clopidogrel
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023
COPD, COPD Exacerbation Acute Trial in Peshawar (Clopidogrel Bisulfate 75Mg Tab)
Not yet recruiting
- COPD
- COPD Exacerbation Acute
- Clopidogrel Bisulfate 75Mg Tab
-
Peshawar, Khyber Pakhtunkhwa, PakistanPulmonology Department, Lady Reading Hospital, Peshawar
Aug 27, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG
- Clopidogrel
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 7, 2023
Stable Chronic Angina Trial in Shiraz (Clopidogrel, Ticagrelor)
Completed
- Stable Chronic Angina
- Clopidogrel
- Ticagrelor
-
Shiraz, Iran, Islamic Republic ofProfessor Kojuri Cardiology Clinic
May 12, 2023
Ischemic Stroke Trial in Guangzhou (Aspirin, Clopidogrel, Alteplase)
Not yet recruiting
- Ischemic Stroke
- Aspirin
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Jun 11, 2023
Coronary Artery Disease, Platelet Reactivity Trial in Nieuwegein (Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- Clopidogrel
-
Nieuwegein, Utrecht, Netherlands
- +1 more
Dec 9, 2022
Ticagrelor Versus Clopidogrel for CMD in AMI: A Retrospective
Completed
- Coronary Heart Disease
- Dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel
-
Hangzhou, Zhejiang, ChinaSecond affiliated Hospital Zhejiang University School of Medicin
Jul 31, 2023
Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)
Active, not recruiting
- Bleeding Complications
- Clopidogrel
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 31, 2022
Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
Recruiting
- Clopidogrel, Poor Metabolism of
- Carotid Stenosis
- Clopidogrel
- Ticagrelor
-
San Donato Milanese, Milan, ItalyIRCCS Policlinico San Donato
Sep 30, 2022
Incidence and Associated Outcomes in Patients With Cerebral Aneurysms Trial in Dallas
Recruiting
- Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
-
Dallas, TexasMethodist Dallas Medical Center
Jul 6, 2023
Coronary Artery Disease Trial in Seoul (Clopidogrel treatment group, No antiplatelet or anticoagulant group)
Recruiting
- Coronary Artery Disease
- Clopidogrel treatment group
- No antiplatelet or anticoagulant group
-
Seoul, Other, Korea, Republic ofSeoul National University Hospital
May 9, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG Oral Tablet
- Clopidogrel tablet
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 18, 2022
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Severe Aortic Stenosis Trial in Seoul (Aspirin single antiplatelet therapy, Clopidogrel single antiplatelet therapy)
Not yet recruiting
- Severe Aortic Stenosis
- Aspirin single antiplatelet therapy
- Clopidogrel single antiplatelet therapy
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 8, 2022
Bioequivalence Trial in Yaroslavl (Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg)
Recruiting
- Bioequivalence
- Clopidogrel film-coated tablet 75 mg
- Plavix® film-coated tablet 75 mg
-
Yaroslavl, Yaroslavl Region, Russian FederationState Autonomous Healthcare Facility of the Yaroslavl Region "Cl
Jun 28, 2023
Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,
Active, not recruiting
- Chronic Kidney Disease (CKD)
- +2 more
- Clopidogrel
- Clopidogrel active metabolite
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Aug 5, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,
Not yet recruiting
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Standard-DAPT of Ticagrelor plus aspirin
- Sequential monotherapy of Ticagrelor and clopidogrel
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Sep 20, 2022
Metabolism of Clopidogrel Trial in Lancaster (Clopidogrel, Omeprazole/Clopidogrel)
Completed
- Metabolism of Clopidogrel
- Clopidogrel
- Omeprazole/Clopidogrel
-
Lancaster, PennsylvaniaAmish Research Clinic
Feb 21, 2022
Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)
Completed
- Thrombosis
- Aspirin、clopidogrel、placebo or SHR2285
- Aspirin、ticagrelor、placebo or SHR2285
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Jun 30, 2022
Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx
Recruiting
- Ischemic Heart Disease
- Clopidogrel monotherapy
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 13, 2022
Acute Coronary Syndrome Trial (Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet)
Not yet recruiting
- Acute Coronary Syndrome
- Rivaroxaban 2.5 Mg Oral Tablet
- +2 more
- (no location specified)
Oct 5, 2022
Intracranial Aneurysm Trial in Gyeonggi-do (Prasugrel group, Clopidogrel group)
Recruiting
- Intracranial Aneurysm
- Prasugrel group
- Clopidogrel group
-
Gyeonggi-do, Yongin-si, Korea, Republic ofYongin Severance hospital, Yonsei university college of medicine
Jul 13, 2022
Myocardial Infarction Patients Who Were PrescribedNovel
Recruiting
- Myocardial Infarction
-
Uijeongbu, Korea, Republic ofThe Catholic University of Korea, Uijeongbu ST. Mary's Hospital
Oct 25, 2022